Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study

OBJECTIVES: Thalidomide and bortezomib have been frequently used for second-line therapy in patients with myeloma relapsing after or refractory to initial melphalan-based treatment, but no randomized trials have been published comparing these two treatment alternatives. METHODS: Thalidomide- and bor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hjorth, Martin, Hjertner, Øyvind, Knudsen, Lene Meldgaard, Gulbrandsen, Nina, Holmberg, Erik, Pedersen, Per Trøllund, Andersen, Niels Frost, Andréasson, Björn, Billström, Rolf, Carlson, Kristina, Carlsson, Margaretha S, Flogegård, Max, Forsberg, Karin, Gimsing, Peter, Karlsson, Torbjörn, Linder, Olle, Nahi, Hareth, Othzén, Annika, Swedin, Agneta
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2012
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3492844/
https://ncbi.nlm.nih.gov/pubmed/22404182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1600-0609.2012.01775.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados